Abstract:The search for robust, reliable biomarkers of schizophrenia remains a
high priority in psychiatry. Biomarkers are valuable because they can
track symptom progression and monitor treatment progress, and may
predict who is at-risk of developing schizophrenia in the future.
Despite the existence of various promising biomarkers that relate to
symptoms across the schizophrenia-spectrum, and despite published
recommendations encouraging multivariate metrics, they are rarely
investigated simultaneously within the sam… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.